Our Magazine
Brussels Morning Online Newspaper
Tuesday, January 19, 2021
No Result
View All Result
  • Home
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • Culture and Society
Brussels Morning Online Newspaper
  • Home
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • Culture and Society
Brussels Morning Online Newspaper
No Result
View All Result
Home EU Institutions Commission

Commission approves second COVID-19 vaccine

Marta Pacheco by Marta Pacheco
7 January 2021
in Commission
Commission approves second COVID-19 vaccine
Share on FacebookShare on Twitter

Brussels (Brussels Morning) The European Commission approved a second COVID-19 vaccine yesterday with an expected bloc-wide rollout to commence next week. 

The inoculation developed by American biotech firm Moderna received the Commission’s authorisation after the European Medicines Agency (EMA) gave it the go-ahead. 

The positive scientific recommendation was based on assessments of the vaccine’s safety, effectiveness and quality endorsed by member states, having already gained approval in the US, Canada and Israel.

The need for a vaccination programme has reached urgent levels recently as the number of infections spike across the EU territory. 

“As of 6 January, among all countries and territories in Europe, almost half have a seven-day incidence of over 150 new cases per 100,000 population, and one quarter are seeing a greater than 10% increase in case incidence over the past two-week period”, said Hans Kluge, regional director of the World Health Organisation (WHO) Europe.

The Commission guaranteed it is working towards providing more COVID-19 vaccines for Europeans, and said that with the Moderna vaccine, the EU bloc will have further 160 million doses.

“Europe has secured up to two billion doses of potential COVID-19 vaccines. We’ll have more than enough safe and effective vaccines for protecting all Europeans”, said President of the European Commission Ursula von der Leyen.

“We are authorising a second safe and effective vaccine from Moderna, which together with BioNTech-Pfizer, will ensure that 460 million doses will be rolled out with increasing speed in the EU, and more will come. Member States have to ensure that the pace of vaccinations follows suit. 

Our efforts will not stop until vaccines are available for everyone in the EU”, said health commissioner Stella Kyriakides.

“As of 6 January, among all countries and territories in Europe, almost half have a seven-day incidence of over 150 new cases per 100,000 population, and one quarter are seeing a greater than 10% increase in case incidence over the past two-week period,” said Hans Kluge, regional director of the World Health Organisation (WHO) Europe.

Curevac vaccine looming

Today, the pharmaceutical giant Bayer announced a partnership with the German bio-pharma company CureVac to support the development of its vaccine against COVID-19, currently in the last phase of clinical trials.

CureVac, based in the German city of Tuebingen, said last month that it hopes to have the first results of the phase three clinical trial of the candidate vaccine based on messenger RNA technology, called CVnCoV, by the end of March.

CureVac wants to produce up to 300 million doses of the vaccine in 2021 and up to 600 million in 2022.

As of 6 January, the UK, Germany and Italy are the three top countries where vaccine administration has been higher, reported Bloomberg, followed by Spain, Poland, Denmark, Romania, Portugal and Hungary.

The @moderna_tx #COVID19 vaccine is approved for use by @EU_Commission, the second in 🇪🇺

Swift vaccinations must now follow.

In the meantime: patience, vigilance and self-discipline are crucial to protect each other. #StrongerTogether pic.twitter.com/rNHYVK8WfV

— Stella Kyriakides (@SKyriakidesEU) January 6, 2021
Tags: Covid-19COVID-19 vaccineEuropean Commission (EC)Main-Slider
Marta Pacheco

Marta Pacheco

Marta Pacheco is the Brussels Morning European Commission Editor. She studied Political Science and Media & Journalism at the Catholic University of Portugal (UCP). A former Blue Book trainee of the European Commission, Marta has a keen interest in global affairs and experience in EU and diplomatic affairs reporting.

Latest post

Parliament wants harsher sanctions on Russia over Navalny’s arrest

Parliament wants harsher sanctions on Russia over Navalny’s arrest

4 mins ago
Poland faces problems with illegal waste imports

Poland faces problems with illegal waste imports

9 hours ago

Most Read

  • Italy’s cannabis industry could rival the legal market in the US

    Italy’s cannabis industry could rival the legal market in the US

    0 shares
    Share 0 Tweet 0
  • Can Armenia and Azerbaijan win peace together?

    0 shares
    Share 0 Tweet 0
  • The West cannot meet Russia half way

    0 shares
    Share 0 Tweet 0
  • How Emiratis shape the European defense agenda

    0 shares
    Share 0 Tweet 0
  • How EU trade and investment deals can fight climate change

    0 shares
    Share 0 Tweet 0

Subscribe
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.